DEALSAGX declares $0.70 quarterly cash dividend, ex-date October 22Sep 10, 2026
EARNINGSCognyte Software narrows full-year guidance to $448 million on software mix shift and profitability accelerationSep 10, 2026
DEALSKTHAF declares THB 0.48 per-share cash dividend, ex-date and record date 23 September 2026Sep 10, 2026
DEALSTreasury's $6bn buyback fails to halt 30-year yield at 5.2%Sep 10, 2026
WORLDChina regulators warn banks against flooding IPO market with low-quality listingsSep 10, 2026
EARNINGSJ.J. McCarthy demoted to third string as Vikings name Wentz backup ahead of Green Bay openerSep 10, 2026
KALAKALA BIO sets November 3 annual meeting; stockholder nomination window closes September 19Sep 9, 2026
MACROTwenty-nine health systems plan to exit Medicare AdvantageSep 9, 2026
DEALSAGX declares $0.70 quarterly cash dividend, ex-date October 22Sep 10, 2026
EARNINGSCognyte Software narrows full-year guidance to $448 million on software mix shift and profitability accelerationSep 10, 2026
DEALSKTHAF declares THB 0.48 per-share cash dividend, ex-date and record date 23 September 2026Sep 10, 2026
DEALSTreasury's $6bn buyback fails to halt 30-year yield at 5.2%Sep 10, 2026
WORLDChina regulators warn banks against flooding IPO market with low-quality listingsSep 10, 2026
EARNINGSJ.J. McCarthy demoted to third string as Vikings name Wentz backup ahead of Green Bay openerSep 10, 2026
KALAKALA BIO sets November 3 annual meeting; stockholder nomination window closes September 19Sep 9, 2026
MACROTwenty-nine health systems plan to exit Medicare AdvantageSep 9, 2026

Eli Lilly says Novo Nordisk is trying to block its clinical trial data

Novo Nordisk (NVO) is attempting to prevent Eli Lilly (LLY) from sharing clinical trial results, Lilly has stated. Lilly's characterization: NVO is choosing to limit disclosure rather than compete on the merits. The accusation draws a…

By Warren Ashby·Jul 22, 2026·1 min read·markets·LLY · NVO
Share
© 2026 NewsMeter